Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study

Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study

Background In nonvalvular atrial fibrillation (AF), oral anticoagulants prevent ischemic strokes and transient ischemic attacks (TIAs), but nonpersistence with vitamin K antagonist (VKA) oral anticoagulant therapy (20–50% at 1 year) is problematic. The precise risk of stroke/TIA after VKA cessation...

Full description

Bibliographic Details
Main Authors: Carlos Martinez, Christopher Wallenhorst, Stephan Rietbrock, Ben Freedman
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulants
atrial fibrillation
stroke
transient ischemic attack
treatment cessation
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014376

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.014376

Similar Items